The independent source for health policy research, polling, and news.
Bernie Sanders, Hillary Clinton, and Medicare for All
In this column for The Wall Street Journal’s Think Tank, Drew Altman explores the differing positions of presidential candidates Hillary Clinton and Bernie Sanders on a single payer or Medicare-for-all health care system and whether Democratic voters consider it an important factor in the 2016 primaries.
Column Read PostPrescription Drugs’ Sizable Share of Health Spending
In this column for The Wall Street Journal’s Think Tank, Drew Altman explains why prescription drug spending may be a larger share of health spending than most people think, depending on how you look at it.
Column Read PostWhat’s the Political Power of Those Newly Insured Under Obamacare?
In this column for The Wall Street Journal’s Think Tank, Drew Altman takes a look at whether the 17 million people newly-insured since 2014 will make an impact in the first presidential election since Affordable Care Act enrollment began.
Column Read PostWhy Painkiller Addiction and Abuse Are Rising Health-Care Priorities
In this column for The Wall Street Journal’s Think Tank, Drew Altman uses new polling to explore why painkiller abuse and addiction is rising as a health issue among state and federal policymakers.
Column Read PostHealth Care and the 2016 Debates
In this column for The Wall Street Journal’s Think Tank, Drew Altman discusses the lack of attention to health in the primary debates and last week’s Democratic forum in South Carolina.
Column Read PostGOP Views of Medicaid Expansion Differ From Conventional Wisdom
In this column for The Wall Street Journal’s Think Tank, Drew Altman examines Republican attitudes on Medicaid expansion in light of the election of Republican Matt Bevin as Kentucky’s next governor.
Column Read Post